tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market
TPST
Tempest Therapeutics
RESEARCH TOOLSreports

Tempest Therapeutics (TPST) Income Statement

1,263 Followers

Tempest Therapeutics Income Statement

Last quarter (Q4 2025), Tempest Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tempest Therapeutics's net income was $-4.02M. See Tempest Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -389.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 26.57M$ 41.64M$ 29.16M$ 34.64M$ 26.99M
Depreciation and Amortization
$ 266.00K$ 389.00K$ 381.00K$ 638.00K$ 374.00K
EBITDA
$ -25.79M$ -40.14M$ -27.66M$ -33.45M$ -26.65M
Operating Income
$ -26.57M$ -42.03M$ -29.16M$ -34.64M$ -26.99M
Other Income/Expenses
$ 313.00K$ 183.00K$ -334.00K$ -1.07M$ -1.32M
Pretax Income
$ -26.26M$ -41.84M$ -29.49M$ -35.71M$ -28.30M
Net Income
$ -26.26M$ -41.84M$ -29.49M$ -35.71M$ -28.30M
Per Share Metrics
Basic EPS
$ -6.33$ -1.50$ -1.91$ -3.18$ -7.80
Diluted EPS
$ -6.33$ -1.50$ -1.91$ -3.18$ -7.80
Weighted Average Shares Outstanding
 4.15M 27.90M 15.42M 888.00K 291.00K
Weighted Average Shares Outstanding (Diluted)
 4.15M 27.90M 15.42M 888.38K 291.56K
Currency in USD

Tempest Therapeutics Earnings and Revenue History